Fauci buoyed by Merck trial of COVID-19 pill

The director of the U.S. National Institute of Allergies and Infectious Diseases, Dr. Anthony Fauci, says the apparent efficacy of Merck's new COVID-19 anti-viral drug is very good news. 'The data are impressive,' he said. (Jim Lo Scalzo/The Associated Press)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting